Erin Oconnor
Psychiatric/Mental Health · Norwich, CTNPI 1932525516
Payments from drug & device makers
Across 282 payments — averaging $13.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$886
- AbbVie$676
- E.r. Squibb & Sons, L.L.C.$292
- Alkermes, Inc.$155
- Otsuka America Pharmaceutical, Inc.$115
- plus $362 from 7 others
What the payments were for
- Food & beverage$3,67998%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 93 | $1,287 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 85 | $886 |
| AbbVie | 65 | $676 |
| E.r. Squibb & Sons, L.L.C. | 12 | $292 |
| Alkermes, Inc. | 8 | $155 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Johnson & Johnson | 2 | $113 |
| Indivior Inc. | 3 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Corium, LLC | 2 | $38 |
| Eisai Inc. | 2 | $33 |
| Braeburn Inc. | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,773 in reported general payments places this provider in the 90th percentile of 679 psychiatric/mental health providers in Connecticut.
See all psychiatric/mental health providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $95,171 |
| SpravatoEsketamine Hcl | 32 | $38,964 |
| VraylarCariprazine Hcl | 25 | $37,042 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 82 | $28,965 |
| VivitrolNaltrexone Microspheres | 12 | $20,064 |
| RexultiBrexpiprazole | 13 | $18,921 |
| Lurasidone Hcl | 48 | $11,142 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,418 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 40 | $5,802 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,302 |
| Buprenorphine Hcl | 17 | $3,383 |
| Clomipramine Hcl | 12 | $3,275 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $3,016 |
| Vilazodone Hcl | 14 | $1,313 |
| Aripiprazole | 37 | $1,097 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,287 | $95,17113 claims |
| Johnson & JohnsonSpravato | $113 | $38,96432 claims |
| AbbVieVraylar | $676 | $37,04225 claims |
| Indivior Inc.Suboxone | $81 | $28,96582 claims |
| Alkermes, Inc.Vivitrol | $155 | $20,06412 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $115 | $18,92113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 679 psychiatric/mental health providers in Connecticut.
Other psychiatric/mental health in Norwich
- Hui HuNorwich$19K
- John KempNorwich$9K
- Renee LacadieNorwich$5K
- Cristina MeehanNew Britain$224K
- Samantha MrazBridgeport$87K
- Philip FrickManchester$31K
- Gia SantoroWest Haven$25K
- Donna DraperDanbury$19K
- Zahida SairitupaDanbury$19K
- Patrick GagnonMilford$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.